Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Reduced by Midland Wealth Advisors LLC

Midland Wealth Advisors LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 459 shares of the medical equipment provider’s stock after selling 35 shares during the quarter. Midland Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $240,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the stock. Moran Wealth Management LLC lifted its position in shares of Intuitive Surgical by 1.7% in the 4th quarter. Moran Wealth Management LLC now owns 1,778 shares of the medical equipment provider’s stock worth $928,000 after buying an additional 29 shares during the last quarter. Main Street Research LLC lifted its position in shares of Intuitive Surgical by 1.9% in the 4th quarter. Main Street Research LLC now owns 79,531 shares of the medical equipment provider’s stock worth $41,512,000 after buying an additional 1,482 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Intuitive Surgical by 24.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 187,398 shares of the medical equipment provider’s stock worth $97,814,000 after buying an additional 36,865 shares during the last quarter. NBT Bank N A NY lifted its position in shares of Intuitive Surgical by 28.0% in the 4th quarter. NBT Bank N A NY now owns 2,489 shares of the medical equipment provider’s stock worth $1,299,000 after buying an additional 544 shares during the last quarter. Finally, Taika Capital LP bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $4,685,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. JPMorgan Chase & Co. raised their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 6.9 %

Intuitive Surgical stock opened at $482.61 on Tuesday. The stock has a market cap of $171.90 billion, a price-to-earnings ratio of 75.29, a PEG ratio of 5.85 and a beta of 1.43. The company’s 50-day moving average price is $570.48 and its two-hundred day moving average price is $531.79. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,309 shares of company stock valued at $7,611,004 in the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.